Investigators ran a simulation of a hypothetical group of 65-year-old men who were at risk for the cancer, as indicated by their prostate-specific antigen (PSA) levels. The costs and benefits of ...

In a randomized trial of prostate cancer screening methods, a blood-based diagnostic test and MRI with subsequent targeted plus systematic prostate biopsies outperformed the standard approach of ...

MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests A new meta-analysis by investigators from Brigham and ...

A trial found no meaningful difference in detection of clinically significantly prostate cancer between multiparametric MRI-based and microultrasound-based biopsy techniques.

MRI should be considered an adjunct to, and not a replacement for, biopsies for men on active surveillance for prostate cancer. MRI does not consistently rule out the presence of Gleason grade group 2 ...

Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound, is ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...

For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...

Exact Imaging, the creator of a first-of-its-kind high-resolution micro-ultrasound system for targeted prostate cancer ...